All In Biotech

Drug Trial Radar · NCT03517176

CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer

A Phase 1 Clinical Trial of CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Exocrine Pancreatic Cancer

Last checked: Nov 19, 2026Latest source record: Aug 28, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Jul 31, 2018

Primary completion

Jun 19, 2020

Study completion Jun 19, 2020

Sponsor

Lead sponsor
Lisata Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
May 7, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

CEND-1, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma

Conditions

  • Pancreatic Cancer
  • Pancreatic Ductal Adenocarcinoma

Interventions

  • CEND-1Drug

    CEND-1 will be provided as concentrate for solution to be administered via IV injection.

  • Nab-paclitaxelDrug

    Nab-paclitaxel will be provided as solution to be administered via IV infusion.

  • GemcitabineDrug

    Gemcitabine will be provided as solution to be administered via IV infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safe doses of CEND-1 when given alone or in combination with nabpaclitaxel and gemcitabineTime frame: Escalation Phase: From Day 1 of the run-in until Day 28 of Cycle 1 (cycle length=28 days)
  2. Optimal Biological Dose (OBD) of CEND-1 when given in combinationTime frame: Expansion Phase: from baseline until treatment discontinuation and approximately 30 days after last dose (cycle length=28 days)

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Queen Elizabeth Hospital

    Woodville South, South Australia, Australia

  • Alfred Hospital

    Melbourne, Victoria, Australia

  • St John of God Hospital

    Subiaco, Western Australia, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.